Labiotech.eu

News and Trends 14 Dec 2016

UPDATE: Bayer seals deal with Monsanto in Dark Side slide

Bloomberg reports that Bayer has increased its bid once more to acquire the world’s least ethical company in order to solidify its position in agrochemicals. Bayer appears hell-bent on a Faustian bargain with Monsanto: the German chemical company has just thrown more money at America’s fourth most hated company in the hope of acquiring it. Despite its […]

December 14, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 14 Dec 2016

What do the CAR-T Patient Deaths Mean for the Future of the Field?

Juno’s JCAR015 study came to a halt for the second time this year after two more patient deaths. But despite the bad news, hopes for CAR-T therapies remain high. Juno Therapeutics again came under scrutiny last month following deaths in its JCAR015 trial. Two patients died from neurotoxicity-triggered cerebral edema, the same condition that killed […]

December 14, 2016 - 7 minutesmins - By Diana Kwon

Interview 13 Dec 2016

Meet the French Seaweed Startup rethinking Bioplastics

Algopack is a French startup manufacturing bio-based materials made from brown algae. It is the first to use it to develop a new generation of bioplastics. Founded by Rémy Lucas in 2010 and managed by David Coti, Algopack offers a breakthrough innovation using marine natural resources as a unique renewable biomass. The company hopes to […]

December 13, 2016 - 3 minutesmins - By Nicolas Sainte-Foie

News and Trends 13 Dec 2016

How Will Biotech Overcome the Huge Challenges of Microbial Resistance?

The emergence of multi-drug resistant pathogens is alarming the scientific community since their growth is increasing at an incredibly fast pace. We gathered a group of experts to discuss how biotech is addressing this pressing concern and what the next big thing will be in the field of antimicrobial resistance. Achim Plum, CCO of Curetis, highlighted that […]

December 13, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Dec 2016

European Pharma closes 2016 by launching new Biotech Startups

Big pharma is already head on starting 2017 with a bang. Pfizer and Bayer are launching US-based startups in oncolytic virus and stem cell therapies. Pharma is wrapping up 2016 by investing in a pair of new ventures. Bayer and Versant have invested $225M to launch BlueRock Therapeutics, which will focus on CNS and cardiovascular diseases. This comes […]

December 13, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 12 Dec 2016

French Biotech Puts a New Lyme Disease Vaccine on the Horizon

There is currently no vaccine for the fast-growing disease in the US, & treatments cost over $1Bn every year. Valneva might have a vaccine to stem the tide. Valneva, a commercial-stage biotech based in Lyon, France, has just received clearance from the FDA and its European counterpart to begin clinical trials for its experimental Lyme Disease […]

December 12, 2016 - 2 minutesmins - By Evelyn Warner

photanol cyanobacteria platform synbio bioplastics

News and Trends 12 Dec 2016

Meet Photanol: Harnessing Cyanobacteria’s Powers for Green Chemicals

Producing fuels and chemicals from CO2 and light has long been a dream of Biotech, and Amsterdam-based Photanol is working on making it an industrial reality with engineered cyanobacteria. I had a chat with Ross Gordon, Director of Business Development, about Photanol’s strategy. Photanol was present at the latest European Bioplastics Conference to present how it uses cyanobacteria, […]

December 12, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 12 Dec 2016

A New Antibiotic from Your Nose! Thanks to Functional Genomics

Could your nose lead to major discoveries in antibiotic production? Genome mining of nose bacteria has revealed a new powerful antibiotic. Functional genomics offers a powerful tool for the isolation and detection of novel antibiotics, as the data obtained from it can be used to describe gene functions and interactions. The human microbiome has been largely […]

December 12, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 12 Dec 2016

With a new €120M Infusion, Pocket NGS CEO talks Success and Strategy

Seeking to disrupt the NGS market, Oxford Nanopore is rolling in cash. Before we heard the news, we sat down with CEO Gordon Sanghera to talk about the company’s success. December has been a stellar month for Oxford Nanopore. Just over a week ago, Oxford Nanopore’s MinION device was used to sequence the whole genome of a number […]

December 12, 2016 - 9 minutesmins - By Evelyn Warner

Screenshot 2016 12 08 at 5.09.55 PM e1481213471552

News and Trends 9 Dec 2016

Paris takes the lead in Digital Health for Diabetes Type 2

The smell of freshly baked baguettes and good news from the capital have brought us this week to France. Voluntis has received market approval for a device that could change the life of millions of people with diabetes type 2, check out this cool company! City: Paris, France Founded: 2001 Employees: 100 Financial data: Total of €29.8M raised in […]

December 9, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Dec 2016

Galapagos gets another Milestone Payment from Gilead

Galapagos is starting a new PhaseIIb/III clinical trial for ulcerative colitis that has triggered a €9.4M milestone payment from Gilead. Can this partnership beat out its many competitors? Galapagos is one of the few billion-euro biotechs in Europe, boasting top-level partnerships with AbbVie for cystic fibrosis and MorphoSys for inflammatory diseases. The company now has news […]

December 9, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Dec 2016

Stories We Didn’t Cover: Next Human CRISPR Trials by Intellia?

Try as we might, we can’t cover all the biotech news out there. During the week, we only pick the top stories to keep you informed but not waste your time. Here’s a roundup of news that didn’t make the cut this week. Amryt has taken out a loan from the European Investment Bank to fund […]

December 9, 2016 - 2 minutesmins - By Evelyn Warner

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

UPDATE: Bayer seals deal with Monsanto in Dark Side slide

What do the CAR-T Patient Deaths Mean for the Future of the Field?

Meet the French Seaweed Startup rethinking Bioplastics

How Will Biotech Overcome the Huge Challenges of Microbial Resistance?

European Pharma closes 2016 by launching new Biotech Startups

French Biotech Puts a New Lyme Disease Vaccine on the Horizon

Meet Photanol: Harnessing Cyanobacteria’s Powers for Green Chemicals

A New Antibiotic from Your Nose! Thanks to Functional Genomics

With a new €120M Infusion, Pocket NGS CEO talks Success and Strategy

Paris takes the lead in Digital Health for Diabetes Type 2

Galapagos gets another Milestone Payment from Gilead

Stories We Didn’t Cover: Next Human CRISPR Trials by Intellia?

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!